Therapeutic options for the treatment of postherpetic neuralgia: A systematic review

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 27, Issue 3, 2013, Pages 268-283

  Khadem, Tina ^a,c   Stevens, Vanessa ^b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Pain; Postherpetic neuralgia; Systematic review; Therapy; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMITRIPTYLINE; CAPSAICIN; DESIPRAMINE; ETIRACETAM; FLUOXETINE; FLUPHENAZINE; GABAPENTIN; GABAPENTIN ENACARBIL; INDOMETACIN; LIDOCAINE; MAGNESIUM SULFATE; METHYLPREDNISOLONE; MORPHINE; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; OXYCODONE; PLACEBO; PREGABALIN; TRAMADOL; TRIAMCINOLONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

ADL DISABILITY; ANALGESIA; APPLICATION SITE ERYTHEMA; APPLICATION SITE REACTION; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EVENING DOSAGE; HUMAN; MCGILL PAIN QUESTIONNAIRE; MORNING DOSAGE; NEUROPATHIC PAIN SCALE; NUMERIC RATING SCALE; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; SKIN TINGLING; SOMNOLENCE; SYSTEMATIC REVIEW; TRANSDERMAL PATCH; VISUAL ANALOG SCALE; XEROSTOMIA;

AMINES; ANALGESICS; ANALGESICS, OPIOID; CYCLOHEXANECARBOXYLIC ACIDS; DRUG APPROVAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; MEDICATION ADHERENCE; NEURALGIA, POSTHERPETIC; OFF-LABEL USE; QUALITY OF LIFE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84883713639     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2013.816408     Document Type: Article

References (63)

1. Philip A, Thakur R. Post herpetic neuralgia. J Palliat Med. 2011;14:765-773.
2. Nalamachu S, Morley-Forster P. Diagnosing and managing postherpetic neuralgia. Drugs Aging. 2012;29:863-869.
3. Ragozzino MW, Melton LJ, 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine. 1982;61:310-316. (Pubitemid 12031812)
4. Watson P. Postherpetic neuralgia. Am Fam Physician. 2011;84:690-692.
5. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clinic Proc. 2007;82:1341-1349. (Pubitemid 350060129)
6. Saks GM. Unmet need in the treatment of postherpetic neuralgia. Am J Manag Care. 2013;19(1 Suppl):S207-S213.
7. Edelsberg JS, Lord C, Oster G. Systematic review and metaanalysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother. 2011;45:1483-1490.
8. Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Region Anesth Pain Med. 1999;24:287-293. (Pubitemid 29344722)
9. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;80:533-538. (Pubitemid 29182702)
10. Kotani N, Kushikata T, Hashimoto H, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med. 2000;343:1514-1519.
11. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002;18:297-301. (Pubitemid 35001155)
12. Amjad M, Mashhood AA. The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia. J Coll Physicians Surgeons Pakistan. 2005;15:683-685. (Pubitemid 43078871)
13. Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an openlabel, non-inferiority two-stage RCT study. Curr Med Res Opin. 2009;25:1663-1676.
14. Binder A, Bruxelle J, Rogers P, Hans G, Bosl I, Baron R. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebocontrolled, multinational efficacy and safety trial. Clin Drug Invest. 2009;29:393-408.
15. Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin. 2010;26:1607-1619.
16. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol. 1989;21(2 Pt 1):265-270. (Pubitemid 19195889)
17. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993;15:510-526. (Pubitemid 23194627)
18. Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol. 2008;7:1106-1112.
19. Backonja MM, Malan TP, Vanhove GF, Tobias JK. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension. Pain Med. 2010;11:600-608.
20. Webster LR, Tark M, Rauck R, Tobias JK, Vanhove GF. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia. BMC Neurol. 2010;10:92.
21. Webster LR, Malan TP, Tuchman MM, Mollen MD, Tobias JK, Vanhove GF. A multicenter, randomized, doubleblind, controlled dose finding study of NGX-4010, a highconcentration capsaicin patch, for the treatment of postherpetic neuralgia. J Pain. 2010;11:972-982.
22. Irving GA, Backonja MM, Dunteman E, et al. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med. 2011;12:99-109.
23. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842. (Pubitemid 28544424)
24. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 2001;94:215-224. (Pubitemid 33016615)
25. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebocontrolled trial. Neurology. 2003;60:1274-1283. (Pubitemid 36460982)
26. Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebocontrolled clinical trial. Pain. 2004;109:26-35. (Pubitemid 38479767)
27. Jean WH, Wu CC, Mok MS, Sun WZ. Starting dose of gabapentin for patients with post-herpetic neuralgia-a doseresponse study. Acta Anaesthesiol Taiwanica. 2005;43:73-77. (Pubitemid 41015190)
28. van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin. 2006;22:375-384. (Pubitemid 44296762)
29. Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain. 2008;9:1006-1017.
30. Irving G, Jensen M, Cramer M, et al. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebocontrolled clinical trial. Clin J Pain. 2009;25:185-192.
31. Jensen MP, Chiang YK, Wu J. Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia. Clin J Pain. 2009;25:286-292.
32. Wallace MS, Irving G, Cowles VE. Gabapentin extendedrelease tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study. Clin Drug Invest. 2010;30:765-776.
33. Backonja MM, Canafax DM, Cundy KC. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin. Pain Med. 2011;12:1098-1108.
34. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982;32:671-673. (Pubitemid 12119035)
35. Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fuphenazine in the treatment of postherpetic neuralgia. Clin J Pain. 2000;16:188-192.
36. Rowbotham MC, Reisner LA, Davies PS, Fields HL. Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain. 2005;6:741-746. (Pubitemid 41579071)
37. Chandra K, Shafiq N, Pandhi P, Gupta S, Malhotra S. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial-the GONIP Trial. Int J Clin Pharmacol Ther. 2006;44:358-363. (Pubitemid 44210010)
38. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009;374:1252-1261.
39. Achar A, Chakraborty PP, Bisai S, Biswas A, Guharay T. Comparative study of clinical efficacy of amitriptyline and pregabalin in postherpetic neuralgia. Acta Dermatovenerol Croatica. 2012;20:89-94.
40. De Benedittis G, Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain. 1996;65:45-51. (Pubitemid 26227687)
41. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837-1841. (Pubitemid 28283261)
42. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59:1015-1021.
43. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebocontrolled trial. Pain. 2003;104:323-331. (Pubitemid 36835899)
44. Kochar DK, Garg P, Bumb RA, et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized doubleblind placebo-controlled study. QJM. 2005;98:29-34.
45. Brill S, Sedgwick PM, Hamann W, Di Vadi PP. Efficacy of intravenous magnesium in neuropathic pain. Br J Anaesth. 2002;89:711-714. (Pubitemid 35277219)
46. Watt JW, Wiles JR, Bowsher DR. Epidural morphine for postherpetic neuralgia. Anaesthesia. 1996;51:647-651. (Pubitemid 26238266)
47. Rowbotham MC, Manville NS, Ren J. Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia. Neurology. 2003;61:866-867. (Pubitemid 37174499)
48. Criscuolo S, Auletta C, Lippi S, Brogi F, Brogi A. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. Acta Neurol Scand. 2005;111:229-232. (Pubitemid 40380457)
49. Quan D, Hammack BN, Kittelson J, Gilden DH. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol. 2006;63:940-942. (Pubitemid 44036293)
50. Hans G, Sabatowski R, Binder A, Boesl I, Rogers P, Baron R. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin. 2009;25:1295-1305.
51. Webster LR, Peppin JF, Murphy FT, Lu B, Tobias JK, Vanhove GF. Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain. Diabetes Res Clin Pract. 2011;93:187-197.
52. Surman OS, Flynn T, Schooley RT, et al. A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia. Psychosomatics. 1990;31:287-292. (Pubitemid 20339552)
53. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998;51:1166-1171. (Pubitemid 28473420)
54. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237-251. (Pubitemid 350051570)
55. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44:293-299.
56. Hoffmann V, Coppejans H, Vercauteren M, Adriaensen H. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain. 1994;10:240-242. (Pubitemid 24280199)
57. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58:347-354. (Pubitemid 24284077)
58. Collins SL, Moore RA, McQuay Hj, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage. 2000;20:449-458.
59. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005;2:e164.
60. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009(3): CD007076.
61. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: a Cochrane review. J Neurol Neurosurg Psychiatry. 2010;81:1372-1373.
62. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;(12): CD008242.
63. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-1256.